🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates a new treatment combination of ixazomib with cyclophos...
Status
Completed
Location
Queen Elizabeth Medical Centre
Start Date
2015-12
Trial ID
NCT02461888
Treatments Being Tested
This phase I/Ia trial finds the best dose and side effects of venetoclax gi...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2022-08-03
Trial ID
NCT04847453
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2014-06-27
Trial ID
NCT02042989
Treatments Being Tested
This phase III trial studies how well lenalidomide in combination with ixaz...
Status
Completed
Location
Cancer Center at Saint Joseph's
Start Date
2022-02-16
Trial ID
NCT03941860
Participants in this study will have been diagnosed with advanced breast ca...
Status
Terminated
Location
Dartmouth-Hitchcock Medical Center
Start Date
2015-06-02
Trial ID
NCT02384746
Treatments Being Tested
The main aim is to evaluate the effect of Ixazomib in combination with lena...
Status
Terminated
Location
Arizona Oncology Associates
Start Date
2017-11-13
Trial ID
NCT03173092
Treatments Being Tested
The MyDRUG study is a type of Precision Medicine trial to treat patients wi...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2019-04-01
Trial ID
NCT03732703
Treatments Being Tested
This phase II trial studies how well daratumumab, ixazomib, and dexamethaso...
Status
Unknown
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2019-07-03
Trial ID
NCT03942224
Treatments Being Tested
Open-label study to evaluate the safety and efficacy of Ixazomib in combina...
Status
Terminated
Location
University Hosptial Toulouse
Start Date
2016-08-05
Trial ID
NCT02897830
Treatments Being Tested
This is a survey among pharmacists who have instructed NINLARO therapy in i...
Status
Completed
Location
Takeda selected site
Start Date
2023-06-01
Trial ID
NCT05882279
Treatments Being Tested